Tom Baker Cancer Center
Calgary, Alberta, Canada
NCT Number: NCT00489060
A trial to determine if cryoablation is as effective as radiation in the treatment of men with localized prostate cancer.
Looking for future studies?
Notify MeMale
Interventional
Phase 3
Calgary, Alberta, Canada
Men with newly diagnosed localized prostate cancer were randomly assigned to cryoablation or external beam radiotherapy (median dose 68 Gy). All patients received neoadjuvant antiandrogen therapy. The primary endpoint was disease progression at 36 months based on a trifecta definition of failure: (a) radiological evidence of metastatic disease or b) initiation of further antineoplastic therapy or c) biochemical failure). Two definitions of biochemical failure were used: 1) rising PSA with a final value >1.0 ng/mL and 2) rise above PSA nadir + 2 ng/mL. Secondary endpoints were overall survival, disease-specific survival, and positive prostate biopsy at 36 months.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 36 months
Time frame: 36 months post treatment
Looking for future studies?
Notify MeUniversity of Calgary
Other
A Randomized Trial of External Beam Radiotherapy Versus Cryoablation in Patients With Clinically Localized Prostate Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06754085
Genital Diseases, Genital Diseases, Male
Guangzhou, China
View Trial DetailsNCT04219059
Genital Diseases, Genital Diseases, Male
Milan, Italy
View Trial DetailsNCT04335682
Castrate Resistant Prostate Cancer, Genital Diseases
San Francisco, California, United States
View Trial DetailsNCT04053842
Genital Diseases, Genital Diseases, Male
London, Ontario, Canada
View Trial Details